Hyponatremia revisited: Translating physiology to practice

Nephron - Physiology

Volumn 108, Issue 3, 2008, Pages

  Hoorn, Ewout J ^a   Zietse, Robert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hyponatremia; Vasopressin; Water balance regulation

Indexed keywords

CLOZAPINE; CONIVAPTAN; DEMECLOCYCLINE; ELECTROLYTE; FUROSEMIDE; HYDROCORTISONE; KAPPA OPIATE RECEPTOR AGONIST; LIXIVAPTAN; PROTEIN; SATAVAPTAN; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; THYROID HORMONE; TOLVAPTAN; UREA; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADRENAL INSUFFICIENCY; ANTIDIURESIS; BRAIN; BURN; CONGESTIVE HEART FAILURE; EXERCISE; EXTRACELLULAR SPACE; FLUID BALANCE; GASTROINTESTINAL DISEASE; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOPITUITARISM; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY; LIVER CIRRHOSIS; LIVER FAILURE; PATHOPHYSIOLOGY; POLYDIPSIA; PRIORITY JOURNAL; PSEUDOHYPONATREMIA; SALT LOSING NEPHRITIS; SHORT SURVEY;

HUMANS; HYPONATREMIA; MODELS, BIOLOGICAL; PHYSICIAN'S PRACTICE PATTERNS; PHYSIOLOGY; WATER-ELECTROLYTE BALANCE;

EID: 42549140764     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119709     Document Type: Short Survey

References (74)

1. Hoorn EJ, Lindemans J, Zietse R: Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 2006;21:70-76.
2. Adrogue HJ, Madias NE: Hyponatremia. N Engl J Med 2000;342:1581-1589.
3. Adrogue HJ: Consequences of inadequate management of hyponatremia. Am J Nephrol 2005;25:240-249.
4. Hoorn EJ, Halperin ML, Zietse R: Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. QJM 2005;98:529-540.
5. Bourque CW, Oliet SH: Osmoreceptors in the central nervous system. Annu Rev Physiol 1997;59:601-619.
6. McKinley MJ, Denton DA, Oldfield BJ, De Oliveira LB, Mathai ML: Water intake and the neural correlates of the consciousness of thirst. Semin Nephrol 2006;26:249-257.
7. Sharif Naeini R, Witty MF, Seguela P, Bourque CW: An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 2006;9:93-98.
8. Oliet SH, Bourque CW: Mechanosensitive channels transduce osmosensitivity in supraoptic neurons. Nature 1993;364:341-343.
9. Burbach JP, Luckman SM, Murphy D, Gainer H: Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001;81: 1197-1267.
10. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA: Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002;82:205-244.
11. Bankir L: Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 2001;51:372-390.
12. Umenishi F, Narikiyo T, Vandewalle A, Schrier RW: cAMP regulates vasopressin-induced AQP2 expression via protein kinase A-independent pathway. Biochim Biophys Acta 2006;1758:1100-1105.
13. Chou CL, Christensen BM, Frische S, Vorum H, Desai RA, Hoffert JD, et al: Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct. J Biol Chem 2004;279:49026-49035.
14. Anderson RJ, Chung HM, Kluge R, Schrier RW: Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985;102:164-168.
15. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, et al: Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005;352:1884-1890.
16. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-137.
17. Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, et al: Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem 2003;278:19280-19285.
18. Kurotani R, Yasuda M, Oyama K, Egashira N, Sugaya M, Teramoto A, et al: Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Mod Pathol 2001;14:791-797.
19. Beukhof CM, Hoorn EJ, Lindemans J, Zietse R: Novel risk factors for hospital-acquired hyponatraemia: a matched case-control study. Clin Endocrinol (Oxf) 2007;66:367-372.
20. Hoorn EJ, Hoffert JD, Knepper MA: Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape. J Am Soc Nephrol 2005;16:2852-2863.
21. Ellison DH, Berl T: Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-2072.
22. Hsu YJ, Chiu JS, Lu KC, Chau T, Lin SH: Biochemical and etiological characteristics of acute hyponatremia in the emergency department. J Emerg Med 2005;29:369-374.
23. Shafiee MA, Charest AF, Cheema-Dhadli S, Glick DN, Napolova O, Roozbeh J, et al: Defining conditions that lead to the retention of water: the importance of the arterial sodium concentration. Kidney Int 2005;67:613-621.
24. Halperin ML, Kamel KS, Sterns R: Hyponatremia in marathon runners. N Engl J Med 2005;353:427-428.
25. Janicic N, Verbalis JG: Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am 2003;32:459-481, vii.
26. Gagnon RF, Halperin ML: Possible mechanisms to explain the absence of hyperkalaemia in Addison's disease. Nephrol Dial Transplant 2001;16:1280-1284.
27. Smith JC, Siddique H, Corrall RJ: Misinterpretation of serum cortisol in a patient with hyponatraemia. BMJ 2004;328:215-216.
28. Diederich S, Franzen NF, Bahr V, Oelkers W: Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 2003;148:609-617.
29. Decaux G, Musch W, Penninckx R, Soupart A: Low plasma bicarbonate level in hyponatremia related to adrenocorticotropin deficiency. J Clin Endocrinol Metab 2003;88:5255-5257.
30. Warner MH, Holding S, Kilpatrick ES: The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol (Oxf) 2006;64:598-599.
31. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C: Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 2007;18:606-612.
32. Rose BD, Post TW: Clinical Physiology of Acid-Base and Electrolyte Disorders, ed 5. New York, McGraw-Hill, 2001.
33. Decaux G, Namias B, Gulbis B, Soupart A: Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol 1996;7:805-810.
34. Maesaka JK, Miyawaki N, Palaia T, Fishbane S, Durham JH: Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia. Kidney Int 2007;71:822-826.
35. Maesaka JK, Venkatesan J, Piccione JM, Decker R, Dreisbach AW: Abnormal urate transport in patients with intracranial disease. Am J Kidney Dis 1992;19:10-15.
36. Chung HM, Kluge R, Schrier RW, Anderson RJ: Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987;83:905-908.
37. McGee S, Abernethy WB 3rd, Simel DL: The rational clinical examination. Is this patient hypovolemic? JAMA 1999;281:1022-1029.
38. Reynolds RM, Padfield PL, Seckl JR: Disorders of sodium balance. BMJ 2006;332:702-705.
39. Carlotti AP, Bohn D, Mallie JP, Halperin ML: Tonicity balance, and not electrolyte-free water calculations, more accurately guides therapy for acute changes in natremia. Intensive Care Med 2001;27:921-924.
40. Turchin A, Seifter JL, Seely EW: Clinical problem-solving. Mind the gap. N Engl J Med 2003;349:1465-1469.
41. Aw TC, Kiechle FL: Pseudohyponatremia. Am J Emerg Med 1985;3:236-239.
42. Hillier TA, Abbott RD, Barrett EJ: Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999;106:399-403.
43. Hamburger S, Koprivica B, Ellerbeck E, Covinsky JO: Thiazide-induced syndrome of inappropriate secretion of antidiuretic hormone. Time course of resolution. JAMA 1981;246:1235-1236.
44. Sonnenblick M, Friedlander Y, Rosin AJ: Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993;103:601-606.
45. Chow KM, Szeto CC, Wong TY, Leung CB, Li PK: Risk factors for thiazide-induced hyponatraemia. QJM 2003;96:911-917.
46. Friedman E, Shadel M, Halkin H, Farfel Z: Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 1989;110:24-30.
47. Robertson GL: Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 2006;119(suppl 1):S36-S42.
48. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J, et al: Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997;349:245-249.
49. Schrier RW: Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 1988;319:1065-1072.
50. Schrier RW: Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med 1988;319:1127-1134.
51. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-2587.
52. Londono MC, Guevara M, Rimola A, Navasa M, Taura P, Mas A, et al: Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130:1135-1143.
53. Goldberg A, Hammerman H, Petcherski S, Nassar M, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al: Hyponatremia and longterm mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 2006;166:781-786.
54. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH: Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-352.
55. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA: Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-328.
56. Hoorn EJ, Lindemans J, Zietse R: Acute and concomitant deterioration of hyponatremia and renal dysfunction associated with heart and liver failure. Clin Nephrol 2006;65:248-255.
57. Noakes TD, Goodwin N, Rayner BL, Branken T, Taylor RK: Water intoxication: a possible complication during endurance exercise. Med Sci Sports Exerc 1985;17:370-375.
58. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt DA, Duncan CN, et al: Hyponatremia among runners in the Boston Marathon. N Engl J Med 2005;352:1550-1556.
59. Noakes TD, Sharwood K, Speedy D, Hew T, Reid S, Dugas J, et al: Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci USA 2005;102:18550-18555.
60. Knochel JP, Dotin LN, Hamburger RJ: Pathophysiology of intense physical conditioning in a hot climate. I. Mechanisms of potassium depletion. J Clin Invest 1972;51:242-255.
61. Siegel AJ, Verbalis JG, Clement S, Mendelson JH, Mello NK, Adner M, et al: Hyponatremia in marathon runners due to inappropriate arginine vasopressin secretion. Am J Med 2007;120:461.e11-461.e17.
62. Thaler SM, Teitelbaum I, Berl T: 'Beer potomania' in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis 1998;31:1028-1031.
63. Musch W, Xhaet O, Decaux G: Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers. QJM 2003;96:421-426.
64. Lohr JW: Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med 1994;96:408-413.
65. Decaux G: Is asymptomatic hyponatremia really asymptomatic? Am J Med 2006;119:S79-S82.
66. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G: Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006;119:71.e1-71.e8.
67. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH: Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007;120(suppl 1):S1-S21.
68. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-2112.
69. Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al: Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 2007;297:1332-1343.
70. Liamis G, Kalogirou M, Saugos V, Elisaf M: Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 2006;21:1564-1569.
71. Hoorn EJ, Zietse R: Tolvaptan for hyponatremia. N Engl J Med 2007;356:961;author reply 962-963.
72. Detmers FJ, de Groot BL, Muller EM, Hinton A, Konings IB, Sze M, et al: Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of action. J Biol Chem 2006;281:14207-14214.
73. Moritz ML, Ayus JC: Hospital-acquired hyponatremia: why are there still deaths? Pediatrics 2004;113:1395-1396.
74. Patel GP, Balk RA: Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther 2007;29:211-229.